Iclusig Ponatinib Film-Coated Tablets 15mg
Iclusig Ponatinib Film-Coated Tablets 15mg

Iclusig Ponatinib Film-Coated Tablets 15mg

MOQ : 50 Boxes

Iclusig Ponatinib Film-Coated Tablets 15mg Specification

  • Salt Composition
  • Ponatinib hydrochloride
  • Life Span
  • Refer to expiry date on packaging
  • Indication
  • Indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior tyrosine kinase inhibitor therapy
  • Pacakaging (Quantity Per Box)
  • 30 Film-coated tablets
  • Origin of Medicine
  • Pharmaceutical preparation
  • Packaging Type
  • Bottle in a box
  • Dosage Form
  • Tablet
  • Drug Type
  • Antineoplastic (anti-cancer) agent
  • Ingredients
  • Ponatinib
  • Physical Form
  • Film-coated tablet
  • Function
  • Treatment of resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)
  • Recommended For
  • Patients with certain types of leukemia and other cancers as prescribed by a physician
  • Dosage
  • As directed by physician, typically 15 mg once daily
  • Dosage Guidelines
  • Follow prescribed dosage schedule, do not exceed recommended dose
  • Suitable For
  • Adults
  • Quantity
  • 30 tablets per pack
  • Storage Instructions
  • Store below 30C, in a dry place, protected from light
  • Prescription Required
  • Yes
  • Warning
  • Use with caution; may cause cardiovascular, hepatic, and pancreatitis complications; regular monitoring required
  • Brand Name
  • Iclusig
  • Strength
  • 15 mg
  • Therapeutic Class
  • Tyrosine kinase inhibitor (TKI)
  • Contraindications
  • Patients with known hypersensitivity to Ponatinib or its excipients
  • Color
  • White to off-white
  • Shape
  • Round
  • Administration Route
  • Oral
  • Common Side Effects
  • Hypertension, rash, abdominal pain, fatigue, headache, blood clots
 

Iclusig Ponatinib Film-Coated Tablets 15mg Trade Information

  • Minimum Order Quantity
  • 50 Boxes
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 500 Boxes Per Month
  • Delivery Time
  • 2-5 Days
  • Main Domestic Market
  • All India
 

About Iclusig Ponatinib Film-Coated Tablets 15mg



Discover the dazzling value of Iclusig Ponatinib Film-Coated Tablets 15mg and benefit from our special Price Cut. This valorous tyrosine kinase inhibitor is impeccably designed to treat adults with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Available in a bottle containing 30 white to off-white, round tablets, each 15 mg dose is expertly formulated for oral administration. Reserve your prescription for Iclusig today and find reliable treatment, under a physician's direction, for challenging cancers. Store below 30C and consult your doctor for optimal use.

Efficient Application and Direction for Use

Iclusig Ponatinib Film-Coated Tablets 15mg are administered orally and are recommended exclusively for adults diagnosed with certain forms of leukemia, according to physician guidance. To maximize efficacy and minimize risk, patients must adhere strictly to their doctor's dosage schedule, typically 15 mg once daily. The tablets should be swallowed with water, without crushing or chewing. Always consult your healthcare provider for application methods tailored to your clinical needs.


Reliable Supply, Competitive Rates, and Certifications

Shipped goods are dispatched from our certified Indian facilities, ensuring you receive authentic Iclusig at the lowest price available. Each pack contains 30 tablets, available for bulk supply through preferred FOB ports. All orders come with strict certification compliance, guaranteeing product quality and safety. Secure the best rate for this advanced antineoplastic agent, designed for professionals committed to exceptional patient care.


FAQ's of Iclusig Ponatinib Film-Coated Tablets 15mg:


Q: How should Iclusig Ponatinib 15mg tablets be taken for best results?

A: Take Iclusig tablets orally once daily as directed by your physician. Swallow the tablets whole with water and avoid crushing or chewing them. Follow your prescribed dosage schedule rigorously and do not exceed the recommended dose.

Q: What therapeutic benefit does Iclusig Ponatinib offer?

A: Iclusig Ponatinib is indicated for adults with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who are resistant or intolerant to prior tyrosine kinase inhibitor therapies, offering a targeted approach for otherwise difficult-to-treat cancers.

Q: When is regular monitoring required during Iclusig treatment?

A: Regular monitoring is recommended throughout Iclusig therapy because the medication can cause cardiovascular, liver, and pancreas-related side effects. Your physician will schedule routine health checks and tests to ensure safety and optimal effectiveness.

Q: Where can I purchase Iclusig Ponatinib tablets?

A: Iclusig Ponatinib 15mg tablets are available by prescription from authorized pharmacies and pharmaceutical traders, particularly in India. Always ensure you source from certified suppliers to guarantee authentic and approved medication.

Q: What process should be followed if a dose of Iclusig is missed?

A: If you miss a dose, take it as soon as you remember on the same day. If a full day has passed, skip the missed dose and resume your regular schedule. Do not double up doses without consulting your physician.

Q: What are the common side effects and contraindications for Iclusig?

A: Common side effects include hypertension, rash, abdominal pain, fatigue, headache, and risk of blood clots. Iclusig is contraindicated in patients with known hypersensitivity to Ponatinib or its excipients. Consult your healthcare provider before starting therapy.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Oncology And Targeted Cancer Therapies Medication Category

Imanib Imatinib Tablets IP 400mg

Imanib Imatinib Tablets IP 400mg

Minimum Order Quantity : 50 Strips

Pacakaging (Quantity Per Box) : 30 Tablets or 100 Tablets per box, depending on packaging

Dosage : 400 mg per tablet, as directed by physician

Life Span : Refer to expiry on the pack, generally 2436 months

Drug Type : Other, Allopathic

Indication : Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST)

Iclusig Ponatinib Tablets 45mg

Iclusig Ponatinib Tablets 45mg

Minimum Order Quantity : 50 Strips

Pacakaging (Quantity Per Box) : 30 tablets

Dosage : 45 mg per tablet, as directed by healthcare provider

Life Span : See packaging for expiry date

Drug Type : Other, Prescription only (Rx)

Indication : Indicated for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)

Osimert Osimertinib Tablets 80mg

Osimert Osimertinib Tablets 80mg

Minimum Order Quantity : 50 Strips

Pacakaging (Quantity Per Box) : 30 tablets per box

Dosage : 80 mg once daily or as directed by physician

Life Span : Refer to package for expiry date

Drug Type : Other, Prescription drug

Indication : Treatment of EGFRpositive nonsmall cell lung cancer

Tagrisso Osimertinib Film-Coated Tablets 80mg

Tagrisso Osimertinib Film-Coated Tablets 80mg

Minimum Order Quantity : 50 Boxes

Pacakaging (Quantity Per Box) : 30 tablets per box

Dosage : 80 mg once daily or as directed by a physician

Life Span : Refer to expiry date on packaging (typically 23 years from manufacture)

Drug Type : Other, Antineoplastic agent

Indication : Treatment of metastatic or locally advanced nonsmall cell lung cancer (NSCLC) with EGFR T790M mutation



Back to top